Enveda Biosciences
Agent55Agent Readiness: 55/100. Top 25%. Measured by StartupHub.ai. Median 41.Trust86Data Trust: 86/100. Top 25%. Measured by StartupHub.ai. Median 61.AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.
About
Enveda Biosciences accelerates drug discovery by learning from nature's chemistry. Their platform reads and translates the natural world's hidden chemistry at unprecedented speed and scale, making billions of years of evolutionary intelligence accessible to drug hunters. Enveda aims to give hope to millions by discovering better medicines for life-enhancing and life-saving treatments.
Listed competitors
Also in this space
AI platform for drug discovery and development, accelerating research with advanced computational tools.
Shares Biotech, Drug Discovery
AI-powered platform for antibody discovery and development to create new medicines.
Shares Biotech, Drug Discovery
Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
Shares Biotech, HealthTech
AI-powered platform for understanding disease biology and accelerating drug discovery.
Shares Biotech, Drug Discovery
AI-guided drug discovery platform for tissue-targeted medicines.
Shares Biotech, Drug Discovery
AI-powered platform for real-time organ physiology to accelerate human-relevant drug discovery.
Shares Biotech, Drug Discovery
Key facts
- Website
- enveda.com
- Headquarters
- Boulder, United States
- Founded
- 2019
- Employees
- 380
- Total funding
- $717M (Series E)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 23 Sept 2026 | Series E | $311M | Catalio Capital Management |
| 1 Feb 2025 | Series C | $130M | Kinnevik, FPV Ventures |
| 11 Jan 2024 | Series D | $150M | |
| 2 May 2023 | Undisclosed round | $50M | Premji Invest |
| 25 Jan 2022 | Undisclosed round | $51M | Premji Invest |
| 9 Feb 2021 | Undisclosed round | $20M | Lux Capital, True Ventures |
| 28 Jan 2020 | Undisclosed round | $5M | True Ventures |
Tech stack
Detected on enveda.com, last scanned 26 Sept 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Tag Manager, Fathom, LinkedIn Insight Tag
- SEO
- Rank Math
- Support
- HubSpot
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Proofpoint
Enveda Biosciences scores 55. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Enveda Biosciences trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Enveda Biosciences is 86 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Enveda Biosciences raised?
Enveda Biosciences has raised a total of $717M in funding. The most recent round on record is Series E.
How many employees does Enveda Biosciences have?
Enveda Biosciences has approximately 380 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Enveda Biosciences
